A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL.
The file type is application/pdf.
In Vivo T-Cell Depletion (TCD) Does Not Improve Rates of Graft-Versus-Host Disease (GVHD) and Transplantation Outcomes in Patients Undergoing Peripheral Blood Allogeneic Hematopoietic Cell Transplant (AHCT)
2011
Biology of Blood and Marrow Transplantation
Preserved Fulltext
than 1000/microlitter following conditioning. Considering platelets, 157 and 12 of patients did not have platelet count less than 20,000 and 100,000/mcrolitter after transplantation respectively. There was no difference for engraftement days between ABO mismatched and matched group. The median RBC transfusion requirement was 7 units prior to 100 days post-HCT and 8 units through one year post-HCT and overall follow-up across all recipients.
doi:10.1016/j.bbmt.2010.12.465
fatcat:usfzktwxejdjnpa7gs4xteaysy